Ticker
Reporting Basis
Period
From
To
Form Type
Report Format
Update Type


ABIOMED INC   FYE=3 (March)

Annual - Income Statement - Company Specific

Fiscal period2021202020192018201720162015201420132012
Period End Date3/31/20213/31/20203/31/20193/31/20183/31/20173/31/20163/31/20153/31/20143/31/20133/31/2012
Products847.52840.88769.43593.75445.30329.54229.95183.28157.61125.29
Funded research and development------------0.360.360.511.09
Total Revenues847.52840.88769.43593.75445.30329.54230.31183.64158.12126.38
Cost of product revenue161.91151.31129.5798.5870.6350.4239.9537.3231.6024.51
Amortization of intangible assets----------------0.111.48
Research and development121.8898.7693.5075.3066.3949.7635.9730.7125.6527.16
Expensed in-process research and development--------------------
Selling, general and administrative334.18341.60321.55262.73218.15164.26125.73107.2584.2371.71
Arbitration decision--------------------
Total Operating Expense617.97591.66544.62436.61355.17264.44201.65175.28141.58124.86
Operating Income (Loss)229.56249.22224.81157.1490.1465.1028.678.3616.541.52
Gain on settlement of investment------------------1.02
Investment income6.7212.178.173.691.550.400.200.12(0.01)0.00
Other income (loss) net51.95(4.56)30.38(0.39)(0.35)0.34(0.10)0.050.330.01
Foreign exchange gain (loss)--------------------
Change in fair value of WorldHeart note receivable and warrant--------------------
Gain on sale of WorldHeart stock--------------------
Pre-Tax Income - Foreign39.0242.0040.02--------4.266.662.31
Pre-Tax Income: United States249.20214.83223.34--------4.2710.200.24
Net Income (loss) before provision for income taxes288.22256.83263.36160.4491.3465.8428.778.5316.862.54
Current- Foreign12.3114.3011.533.401.071.591.280.531.000.26
Current: Federal8.62----0.757.311.690.46(0.10)0.10--
Current: State12.386.560.561.495.052.110.42(0.11)----
Provision for income taxes62.7053.824.3448.2739.2327.69(84.92)1.181.851.05
Deferred: Federal30.4133.24(7.15)38.8523.0118.77(66.14)0.830.830.83
Deferred: State(2.38)1.58(1.50)(1.01)(0.35)1.28(13.43)0.04(0.07)(0.04)
Deferred: Foreign1.35(1.87)0.914.793.142.24(7.52)------
Net Income (loss) Available to Common Shareholders225.53203.01259.02112.1752.1238.15113.697.3515.011.50
Net Earnings Per Share (Basic)5.004.495.772.541.210.902.800.190.380.04
Net Earnings Per Share (Diluted)4.944.435.612.451.170.852.650.180.370.04
Weighted Average Shares Outstanding (Basic)45.1445.1844.9144.1543.2442.2040.6339.3339.1138.37
Weighted Average Shares Outstanding (Diluted)45.6745.8246.1545.8544.6644.9042.8641.6141.0540.17